tradmap

OMDA Earnings Omada Health, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$10 -$5 $0 2023 2024 2025
EPS
Revenue (annual)
$0 $130M $260M 2023 2024 2025
Revenue
Net income (annual)
-$68M -$34M $0 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $1 $0 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $44M $88M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$19M -$7M $5M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–11 of 11
Q2 20262026-06-300.082026-08-0710-Q
Q1 20262026-03-31-0.052026-05-0810-Q
Q4 2025 (derived)2025-12-311.102026-03-0610-K
FY 20252025-12-31-0.352026-03-0610-K
Q3 20252025-09-30-0.062025-11-0710-Q
Q2 20252025-06-30-0.242025-08-0810-Q
Q1 20252025-03-31-1.15——
FY 20242024-12-31-6.11——
Q3 20242024-09-30-1.18——
Q2 20242024-06-30-1.40——
FY 20232023-12-31-9.52——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.